Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc. (RYAM) Financial Performance & Income Statement Overview
Analyze Rayonier Advanced Materials Inc. (RYAM) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Rayonier Advanced Materials Inc. (RYAM) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Rayonier Advanced Materials Inc. RYAM financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $340.03M | $355.97M | $422.50M | $401.10M |
| Cost of Revenue | $316.09M | $331.91M | $385.56M | $357.53M |
| Gross Profit | $23.95M | $24.05M | $36.94M | $43.57M |
| Gross Profit Ratio | $0.07 | $0.07 | $0.09 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $17.74M | $23.26M | $26.69M | $22.68M |
| Operating Expenses | $17.74M | $39.15M | $25.93M | $60.37M |
| Total Costs & Expenses | $337.00M | $371.06M | $412.25M | $417.90M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $23.00M | -$23.60M | $23.11M | $20.48M |
| Depreciation & Amortization | $0.00 | $31.25M | $35.19M | $35.19M |
| EBITDA | -$3.00M | $17.68M | $44.97M | $19.004M |
| EBITDA Ratio | -$0.009 | $0.05 | $0.11 | $0.05 |
| Operating Income | -$907000.00 | -$15.09M | $11.009M | -$16.80M |
| Operating Income Ratio | -$0.003 | -$0.04 | $0.03 | -$0.04 |
| Other Income/Expenses (Net) | -$24.92M | -$22.08M | -$29.95M | -$19.87M |
| Income Before Tax | -$25.83M | -$37.17M | -$18.94M | -$36.67M |
| Income Before Tax Ratio | -$0.08 | -$0.10 | -$0.04 | -$0.09 |
| Income Tax Expense | $339.00M | -$5.20M | -$3.00M | -$4.07M |
| Net Income | -$363.03M | -$31.97M | -$16.22M | -$32.60M |
| Net Income Ratio | -$1.07 | -$0.09 | -$0.04 | -$0.08 |
| EPS | -$5.46 | -$0.48 | -$0.25 | -$0.49 |
| Diluted EPS | -$5.46 | -$0.48 | -$0.25 | -$0.49 |
| Weighted Avg Shares Outstanding | $66.55M | $65.75M | $65.93M | $65.89M |
| Weighted Avg Shares Outstanding (Diluted) | $66.55M | $65.75M | $65.93M | $65.89M |
The company's financials show resilient growth, with revenue advancing from $401.10M in Q3 2024 to $340.03M in Q2 2025. Gross profit remained healthy with margins at 7% in Q2 2025 compared to 11% in Q3 2024. Operating income hit -$907000.00 last quarter, sustaining a consistent -0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$3.00M. Net income dropped to -$363.03M, while earnings per share reached -$5.46. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan